Mobile Health Technology for Enhancing the COVID-19 Response in Africa: A Potential Game Changer?
Date
2020-05
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Disclosure: J. B. N. is also a coprincipal investigator of TOGETHER, an adaptive randomized clinical trial of novel agents for treatment of high-risk outpatient COVID-19 patients in South Africa; supported by the Bill & Melinda Gates Foundation; and a member of COVID-19 Scientific Committee of the Democratic Republic of the Congo. R. T. L. is an infectious disease specialist and global health researcher with support from the Canadian Institutes of Health Research, Michael Smith Foundation, for Health Research and Grand Challenges Canada, and is cofounder of the WelTel (www.weltelhealth.com), as well as a member of the roster of experts for the WHO Task Force for Digital Health. He served on the front lines of the 2003 SARS epidemic and led a consortium on the Ebola outbreak response in 2014. Sir Zumla is co-PI of the Pan-African Network on Emerging and Re-Emerging Infections (PANDORA-ID-NET: https://www.pandora-id.net/) funded by the European and Developing Countries Clinical Trials Partnership the EU Horizon 2020 Framework Programme for Research and Innovation. Sir Zumla is recipient of a National Institutes of Health Research senior investigator award.
Description
Keywords
Mobile Health Technology, COVID-19, Africa